Skeletal Muscle Mass Index (SMI)
ورودیهای بالینی بیمار
حداقل ۳ — حداکثر ۶۰ • واحد: kg
حداقل ۱.۲ — حداکثر ۲.۳ • واحد: m
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
The Skeletal Muscle Mass Index (SMI) calculates assessing cognitive function, clinical frailty grade, and fall risk in older adult populations. Key inputs include asm kg. Scores guide deprescribing high-risk medications, implementing multimodal fall-prevention plans, and cognitive support. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Appendicular muscle mass / height^2; EWGSOP2 low-muscle cutoffs: men <7.0, women <5.5 kg/m2.
Clinical Indication
The Skeletal Muscle Mass Index (SMI) is indicated for bedside clinical practice to support Appendicular muscle mass / height^2; EWGSOP2 low-muscle cutoffs: men <7.0, women <5.5 kg/m2.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Older adults aged 65 years and older presenting with frailty syndromes, dementia, delirium, falls, and polypharmacy. Clinical application is indicated across Geriatric medicine wards, skilled nursing facilities, memory clinics, and outpatient geriatric care.
Limitations & Contraindications
Elderly patients routinely present with atypical disease manifestations, such as hypoactive delirium without fever in systemic bacteremia.
Clinical Pearls & Action Plan
Comprehensive geriatric assessment incorporating activities of daily living (ADLs) and Beers criteria medication review is essential.
SMI = appendicular skeletal muscle mass (kg) / height (m)^2
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| asm_kg | float | Yes | Appendicular skeletal muscle mass (DXA/BIA)(kg) |
| height_m | float | Yes | Height(m) |
| sex | string | Yes | Sex |
Evidence-Based References (EBM)
- Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus (EWGSOP2). Age Ageing. 2019;48(1):16-31.